Budesonide nasal irrigations in the postoperative management of chronic rhinosinusitis

David W. Jang, Vasileios A. Lachanas, Jamie Segel, Stilianos E Kountakis

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Background: Nasal steroids play an important role in the postoperative management of patients with chronic rhinosinusitis (CRS). However, commercially available nasal steroid sprays may not deliver adequate amounts of medication to the entire postoperative sinus cavity. The off-label use of budesonide nasal irrigation (BNI) theoretically solves this problem by delivering concentrated steroid solution through a high-pressure, high-volume system. Several studies have attested to the safety of BNI, but there are very few reports of its efficacy. Methods: This is a retrospective review of prospectively-collected data. We identified 60 patients who were prescribed BNI postoperatively, but had a lapse in therapy for 1 month or longer. The 20-item Sinonasal Outcomes Test (SNOT-20) and Lund-Kennedy endoscopy scores while the patients were using BNI were compared with scores from the same patients while they were not using BNI. Student paired t test was used for statistical analysis. Results: Thirty patients had eosinophilic chronic rhinosinusitis (eCRS) with polyps (eCRSwNP), 13 had allergic fungal sinusitis (AFS), 13 had Samter's triad (ST), and 4 had eosinophilic chronic rhinosinusitis without polyps (eCRSsNP). Mean follow-up time was 25 months (range, 2-89 months). Overall, SNOT-20 scores were significantly lower with BNI (p < 0.05). On subgroup analysis, SNOT-20 scores were significantly improved with BNI for patients with eCRS and Samter's triad (p = 0.04, 0.03). Endoscopy scores were significantly improved only in the eCRS group (p = 0.02). Conclusion: The addition of BNI is beneficial in the postoperative management of patients with CRS.

Original languageEnglish (US)
Pages (from-to)708-711
Number of pages4
JournalInternational Forum of Allergy and Rhinology
Volume3
Issue number9
DOIs
StatePublished - Sep 1 2013

Fingerprint

Nasal Lavage
Budesonide
Steroids
Polyps
Endoscopy
Off-Label Use
Nasal Sprays
Sinusitis
Nose
Students
Safety
Pressure

Keywords

  • Budesonide
  • Nasal steroids
  • Postoperative outcomes
  • Rhinosinusitis
  • Sinusitis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Otorhinolaryngology

Cite this

Budesonide nasal irrigations in the postoperative management of chronic rhinosinusitis. / Jang, David W.; Lachanas, Vasileios A.; Segel, Jamie; Kountakis, Stilianos E.

In: International Forum of Allergy and Rhinology, Vol. 3, No. 9, 01.09.2013, p. 708-711.

Research output: Contribution to journalArticle

@article{ef7f3fa9531747009e1fb8f6d88040d0,
title = "Budesonide nasal irrigations in the postoperative management of chronic rhinosinusitis",
abstract = "Background: Nasal steroids play an important role in the postoperative management of patients with chronic rhinosinusitis (CRS). However, commercially available nasal steroid sprays may not deliver adequate amounts of medication to the entire postoperative sinus cavity. The off-label use of budesonide nasal irrigation (BNI) theoretically solves this problem by delivering concentrated steroid solution through a high-pressure, high-volume system. Several studies have attested to the safety of BNI, but there are very few reports of its efficacy. Methods: This is a retrospective review of prospectively-collected data. We identified 60 patients who were prescribed BNI postoperatively, but had a lapse in therapy for 1 month or longer. The 20-item Sinonasal Outcomes Test (SNOT-20) and Lund-Kennedy endoscopy scores while the patients were using BNI were compared with scores from the same patients while they were not using BNI. Student paired t test was used for statistical analysis. Results: Thirty patients had eosinophilic chronic rhinosinusitis (eCRS) with polyps (eCRSwNP), 13 had allergic fungal sinusitis (AFS), 13 had Samter's triad (ST), and 4 had eosinophilic chronic rhinosinusitis without polyps (eCRSsNP). Mean follow-up time was 25 months (range, 2-89 months). Overall, SNOT-20 scores were significantly lower with BNI (p < 0.05). On subgroup analysis, SNOT-20 scores were significantly improved with BNI for patients with eCRS and Samter's triad (p = 0.04, 0.03). Endoscopy scores were significantly improved only in the eCRS group (p = 0.02). Conclusion: The addition of BNI is beneficial in the postoperative management of patients with CRS.",
keywords = "Budesonide, Nasal steroids, Postoperative outcomes, Rhinosinusitis, Sinusitis",
author = "Jang, {David W.} and Lachanas, {Vasileios A.} and Jamie Segel and Kountakis, {Stilianos E}",
year = "2013",
month = "9",
day = "1",
doi = "10.1002/alr.21189",
language = "English (US)",
volume = "3",
pages = "708--711",
journal = "International Forum of Allergy and Rhinology",
issn = "2042-6976",
publisher = "Wiley-Blackwell",
number = "9",

}

TY - JOUR

T1 - Budesonide nasal irrigations in the postoperative management of chronic rhinosinusitis

AU - Jang, David W.

AU - Lachanas, Vasileios A.

AU - Segel, Jamie

AU - Kountakis, Stilianos E

PY - 2013/9/1

Y1 - 2013/9/1

N2 - Background: Nasal steroids play an important role in the postoperative management of patients with chronic rhinosinusitis (CRS). However, commercially available nasal steroid sprays may not deliver adequate amounts of medication to the entire postoperative sinus cavity. The off-label use of budesonide nasal irrigation (BNI) theoretically solves this problem by delivering concentrated steroid solution through a high-pressure, high-volume system. Several studies have attested to the safety of BNI, but there are very few reports of its efficacy. Methods: This is a retrospective review of prospectively-collected data. We identified 60 patients who were prescribed BNI postoperatively, but had a lapse in therapy for 1 month or longer. The 20-item Sinonasal Outcomes Test (SNOT-20) and Lund-Kennedy endoscopy scores while the patients were using BNI were compared with scores from the same patients while they were not using BNI. Student paired t test was used for statistical analysis. Results: Thirty patients had eosinophilic chronic rhinosinusitis (eCRS) with polyps (eCRSwNP), 13 had allergic fungal sinusitis (AFS), 13 had Samter's triad (ST), and 4 had eosinophilic chronic rhinosinusitis without polyps (eCRSsNP). Mean follow-up time was 25 months (range, 2-89 months). Overall, SNOT-20 scores were significantly lower with BNI (p < 0.05). On subgroup analysis, SNOT-20 scores were significantly improved with BNI for patients with eCRS and Samter's triad (p = 0.04, 0.03). Endoscopy scores were significantly improved only in the eCRS group (p = 0.02). Conclusion: The addition of BNI is beneficial in the postoperative management of patients with CRS.

AB - Background: Nasal steroids play an important role in the postoperative management of patients with chronic rhinosinusitis (CRS). However, commercially available nasal steroid sprays may not deliver adequate amounts of medication to the entire postoperative sinus cavity. The off-label use of budesonide nasal irrigation (BNI) theoretically solves this problem by delivering concentrated steroid solution through a high-pressure, high-volume system. Several studies have attested to the safety of BNI, but there are very few reports of its efficacy. Methods: This is a retrospective review of prospectively-collected data. We identified 60 patients who were prescribed BNI postoperatively, but had a lapse in therapy for 1 month or longer. The 20-item Sinonasal Outcomes Test (SNOT-20) and Lund-Kennedy endoscopy scores while the patients were using BNI were compared with scores from the same patients while they were not using BNI. Student paired t test was used for statistical analysis. Results: Thirty patients had eosinophilic chronic rhinosinusitis (eCRS) with polyps (eCRSwNP), 13 had allergic fungal sinusitis (AFS), 13 had Samter's triad (ST), and 4 had eosinophilic chronic rhinosinusitis without polyps (eCRSsNP). Mean follow-up time was 25 months (range, 2-89 months). Overall, SNOT-20 scores were significantly lower with BNI (p < 0.05). On subgroup analysis, SNOT-20 scores were significantly improved with BNI for patients with eCRS and Samter's triad (p = 0.04, 0.03). Endoscopy scores were significantly improved only in the eCRS group (p = 0.02). Conclusion: The addition of BNI is beneficial in the postoperative management of patients with CRS.

KW - Budesonide

KW - Nasal steroids

KW - Postoperative outcomes

KW - Rhinosinusitis

KW - Sinusitis

UR - http://www.scopus.com/inward/record.url?scp=84884820674&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884820674&partnerID=8YFLogxK

U2 - 10.1002/alr.21189

DO - 10.1002/alr.21189

M3 - Article

C2 - 23776108

AN - SCOPUS:84884820674

VL - 3

SP - 708

EP - 711

JO - International Forum of Allergy and Rhinology

JF - International Forum of Allergy and Rhinology

SN - 2042-6976

IS - 9

ER -